PS Ratio: 13.82

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 13.82 is 63% below its estimated 5-year average of 37.49, near the low end of its estimated 5-year range (1.58–284.71).

As of 2026-10-06T22:56:05.616Z. 64.06% above its estimated 12-month average of 8.42.

CLGN PS Ratio Metrics

P/S vs. estimated history

At 13.82, P/S is near its estimated 9-year median — higher than 52% of readings in its estimated 9-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for CollPlant Biotechnologies Ltd. (CLGN)?

The P/S ratio for CLGN stock is 13.82.

Is CollPlant Biotechnologies Ltd.'s P/S ratio high or low?

The P/S ratio of 13.82 is 63% below its estimated 5-year average of 37.49, near the low end of its estimated 5-year range (1.58–284.71).

What is the estimated TTM average P/S ratio for CollPlant Biotechnologies Ltd. (CLGN)?

The estimated TTM average P/S ratio for CLGN stock is 8.42.

What is the estimated 3Y average P/S ratio for CollPlant Biotechnologies Ltd. (CLGN)?

The estimated 3Y average P/S ratio for CLGN stock is 21.28.

What is the estimated 5Y average P/S ratio for CollPlant Biotechnologies Ltd. (CLGN)?

The estimated 5Y average P/S ratio for CLGN stock is 37.49.

Showing the most recent 260 of 2,182 data points. The chart above shows the full history.

Related Metrics